| Patent Agent Finder |
|||||||||||||||
![]() |
|||||||||||||||
| The PatentlyProtected.com |
IP Tutor |
||||||||||||||
| IP Q&A Forum |
|||||||||||||||
| IP Links |
|||||||||||||||
| Territory Planner Tool |
|||||||||||||||
| Back to Patent Questions Index |
Ask a question... |
||||||||||||||
| How did the EC Biotechnology directive change European patent law? The European Biotechnology Directive is intended to clarify and harmonise laws relating to biotechnology inventions. The EPO has also fully implemented directive into the EPC. Article 53(b) states that “European patents shall not be granted in respect of plant or animals varieties or essentially biological processes for the production of plants or animals; this provision does not apply to microbiological processes or products thereof.” Harvard/Oncomouse, as there is no clear definition of a an ‘animal variety’, but a transgenic animal like the oncomouse is not one. It was held that mammals and rodents constitute a taxonomic classification unit higher than animal variety / race animale/Teirart and are therefore not excluded. Article 53(a): Plant Genetic Systems which went through a controversial decision that genetically engineered plants are not patentable.But in Norvatis, the Enlarged Board held that a claim wherein specific plant varieties are not individually claimed is not excluded from patentability under Article 53(b) EPC even though it may embrace plant varieties. This decision put an end to the questions on plant variety. |
|||||||||||||||
| © 2005 PatentlyProtected.com All rights reserved Nothing on this site constitutes legal advice, an offer, an offer to treat or a legal relationship. Always check with your IP consultant. |
|||||||||||||||